Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation CADTH. Neurofeedback and biofeedback for post-traumatic stress disorder, generalized anxiety disorder, and depression: a review of the clinical evidence and guidelines.
. Ottawa: Canadian Agency for Drugs and Technologies in Health (CADTH). 2012 Authors' conclusions Evidence from mostly preliminary analyses raised the possibility that biofeedback and neurofeedback may have a potential for the treatment of post-traumatic stress disorder, generalized anxiety disorder, or depression. No relevant evidence-based guidelines were identified.
Indexing Status Subject indexing assigned by CRD MeSH Anxiety Disorders; Biofeedback, Psychology; Depressive Disorder; Neurofeedback; Stress Disorders, Post-Traumatics Language Published English Country of organisation Canada English summary An English language summary is available. Address for correspondence Canadian Agency for Drugs and Technologies in Health (CADTH), 865 Carling Avenue, Suite 600, K1S 5S8 Ottawa, Ontario Canada Email: htainfo@cadth.ca AccessionNumber 32012000687 Date abstract record published 28/09/2012 |